Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors

Molecular Neurobiology

Volumn 54, Issue 3, 2017, Pages 1745-1758

  Matsuzaki, Yasunori ^a   Konno, Ayumu ^a   Mukai, Ryo ^a   Honda, Fumiaki ^a   Hirato, Masafumi ^a   Yoshimoto, Yuhei ^a   Hirai, Hirokazu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adeno associated virus serotype 9 vector; Cerebellum; Common marmoset; Gene transfer; Spinal cord; Stereology

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; GREEN FLUORESCENT PROTEIN;

ADENO ASSOCIATED VIRUS 9; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AXON; BRAIN REGION; CALLITRICHINAE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CEREBELLUM CORTEX; CEREBROSPINAL FLUID FLOW; CISTERNA MAGNA; CONTROLLED STUDY; DIFFUSION; EXPERIMENTAL MODEL; FEMALE; GENETIC TRANSDUCTION; INFERIOR OLIVARY NUCLEUS; MALE; MEDULLA OBLONGATA; MOTONEURON; NONHUMAN; PONTINE NUCLEUS; SENSORY NERVE CELL; SPINAL CORD; SPINAL GANGLION; SPINOCEREBELLAR TRACT; SUBARACHNOID SPACE; TRANSCYTOSIS; VESTIBULAR NUCLEUS; VIRAL GENE DELIVERY SYSTEM; ADMINISTRATION AND DOSAGE; ANIMAL; CALLITHRIX; CHEMISTRY; DEPENDOPARVOVIRUS; DRUG EFFECTS; GENE VECTOR; GENETICS; MARMOTA; METABOLISM; PROCEDURES; RAT; WOODCHUCK HEPATITIS VIRUS;

ANIMALS; CALLITHRIX; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CISTERNA MAGNA; DEPENDOVIRUS; FEMALE; GENETIC VECTORS; HEPATITIS B VIRUS, WOODCHUCK; MALE; MARMOTA; RATS; TRANSDUCTION, GENETIC;

EID: 84958757615     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-9777-6     Document Type: Article

References (45)

1. Kishi N, Sato K, Sasaki E, Okano H (2014) Common marmoset as a new model animal for neuroscience research and genome editing technology. Develop Growth Differ 56(1):53–62. doi:10.1111/dgd.12109
2. Cox TM, Cachon-Gonzalez MB (2012) The cellular pathology of lysosomal diseases. J Pathol 226(2):241–254. doi:10.1002/path.3021
3. Noh H, Lee JI (2014) Current and potential therapeutic strategies for mucopolysaccharidoses. J Clin Pharm Ther 39(3):215–224. doi:10.1111/jcpt.12136
4. Kesidou E, Lagoudaki R, Touloumi O, Poulatsidou KN, Simeonidou C (2013) Autophagy and neurodegenerative disorders. Neural RegenRes 8(24):2275–2283. doi:10.3969/j.issn.1673-5374.2013.24.007
5. Roussel BD, Kruppa AJ, Miranda E, Crowther DC, Lomas DA, Marciniak SJ (2013) Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol 12(1):105–118. doi:10.1016/S1474-4422(12)70238-7
6. Ward SM, Himmelstein DS, Lancia JK, Binder LI (2012) Tau oligomers and tau toxicity in neurodegenerative disease. Biochem Soc Trans 40(4):667–671. doi:10.1042/BST20120134
7. Nobrega C, Nascimento-Ferreira I, Onofre I, Albuquerque D, Hirai H, Deglon N, de Almeida LP (2013) Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. PLoS One 8(1):e52396. doi:10.1371/journal.pone.0052396
8. Iwata N, Sekiguchi M, Hattori Y, Takahashi A, Asai M, Ji B, Higuchi M, Staufenbiel M et al (2013) Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice. Sci Rep 3:1472. doi:10.1038/srep01472
9. Torashima T, Koyama C, Iizuka A, Mitsumura K, Takayama K, Yanagi S, Oue M, Yamaguchi H et al (2008) Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia. EMBO Rep 9(4):393–399. doi:10.1038/embor.2008.31
10. Flotte TR (2000) Size does matter: overcoming the adeno-associated virus packaging limit. Respir Res 1(1):16–18. doi:10.1186/rr6
11. Murlidharan G, Samulski RJ, Asokan A (2014) Biology of adeno-associated viral vectors in the central nervous system. Front Mol Neurosci 7:76. doi:10.3389/fnmol.2014.00076
12. Masamizu Y, Okada T, Kawasaki K, Ishibashi H, Yuasa S, Takeda S, Hasegawa I, Nakahara K (2011) Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9. Neuroscience 193:249–258. doi:10.1016/j.neuroscience.2011.06.080
13. Bevan AK, Duque S, Foust KD, Morales PR, Braun L, Schmelzer L, Chan CM, McCrate M et al (2011) Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol Ther 19(11):1971–1980. doi:10.1038/mt.2011.157
14. Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ (2011) Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19(6):1058–1069. doi:10.1038/mt.2011.72
15. Gray SJ, Nagabhushan Kalburgi S, McCown TJ, Jude Samulski R (2013) Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther 20(4):450–459. doi:10.1038/gt.2012.101
16. Hinderer C, Bell P, Vite CH, Louboutin JP, Grant R, Bote E, Yu H, Pukenas B et al (2014) Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna. Mol Ther Methods Clin Dev 1:14051. doi:10.1038/mtm.2014.51
17. Meyer K, Ferraiuolo L, Schmelzer L, Braun L, McGovern V, Likhite S, Michels O, Govoni A et al (2015) Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose–response study in mice and nonhuman primates. Mol Ther 23(3):477–487. doi:10.1038/mt.2014.210
18. Samaranch L, Salegio EA, San Sebastian W, Kells AP, Bringas JR, Forsayeth J, Bankiewicz KS (2013) Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum Gene Ther 24(5):526–532. doi:10.1089/hum.2013.005
19. Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, Lamarre C, Forsayeth J et al (2012) Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 23(4):382–389. doi:10.1089/hum.2011.200
20. Yoon SY, Bagel JH, O’Donnell PA, Vite CH, Wolfe JH (2015) Clinical improvement of alpha-mannosidosis cat following a single cisterna magna infusion of AAV1. Mol Ther. doi:10.1038/mt.2015.168
21. Matsuzaki Y, Oue M, Hirai H (2014) Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter. J Neurosci Methods 223:133–143. doi:10.1016/j.jneumeth.2013.12.004
22. Loeb JE, Cordier WS, Harris ME, Weitzman MD, Hope TJ (1999) Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum Gene Ther 10(14):2295–2305. doi:10.1089/10430349950016942
23. Koeppen AH (2005) The pathogenesis of spinocerebellar ataxia. Cerebellum 4(1):62–73. doi:10.1080/14734220510007950
24. Seki T, Adachi N, Abe-Seki N, Shimahara T, Takahashi H, Yamamoto K, Saito N, Sakai N (2011) Elucidation of the molecular mechanism and exploration of novel therapeutics for spinocerebellar ataxia caused by mutant protein kinase C gamma. J Pharmacol Sci 116(3):239–247
25. Zhang Y, Kaczmarek LK (2015) Kv3.3 potassium channels and spinocerebellar ataxia. J Physiol. doi:10.1113/JP271343
26. Takayama K, Torashima T, Horiuchi H, Hirai H (2008) Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter. Neurosci Lett 443(1):7–11. doi:10.1016/j.neulet.2008.07.058
27. Gallay MN, Jeanmonod D, Liu J, Morel A (2008) Human pallidothalamic and cerebellothalamic tracts: anatomical basis for functional stereotactic neurosurgery. Brain Struct Funct 212(6):443–463. doi:10.1007/s00429-007-0170-0
28. Vaudano E, Legg CR (1992) Cerebellar connections of the ventral lateral geniculate nucleus in the rat. Anat Embryol 186(6):583–588
29. Glickstein M (2000) How are visual areas of the brain connected to motor areas for the sensory guidance of movement? Trends Neurosci 23(12):613–617
30. Huda F, Konno A, Matsuzaki Y, Goenawan H, Miyake K, Shimada T, Hirai H (2014) Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model. Mol Ther Methods Clin Dev. Article number: 14032. doi:10.1038/mtm.2014.32
31. Kirik D, Bjorklund A (2003) Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors. Trends Neurosci 26(7):386–392. doi:10.1016/S0166-2236(03)00164-4
32. Wolf DA, Banerjee S, Hackett PB, Whitley CB, McIvor RS, Low WC (2015) Gene therapy for neurologic manifestations of mucopolysaccharidoses. Expert Opin Drug Deliv 12(2):283–296. doi:10.1517/17425247.2015.966682
33. Heldermon CD, Ohlemiller KK, Herzog ED, Vogler C, Qin E, Wozniak DF, Tan Y, Orrock JL et al (2010) Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB. Mol Ther 18(5):873–880. doi:10.1038/mt.2010.17
34. Gholizadeh S, Tharmalingam S, Macaldaz ME, Hampson DR (2013) Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice. Human Gene Ther Methods 24(4):205–213. doi:10.1089/hgtb.2013.076
35. McLean JR, Smith GA, Rocha EM, Hayes MA, Beagan JA, Hallett PJ, Isacson O (2014) Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection. Neurosci Lett 576:73–78. doi:10.1016/j.neulet.2014.05.044
36. Miyake N, Miyake K, Yamamoto M, Hirai Y, Shimada T (2011) Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors. Brain Res 1389:19–26. doi:10.1016/j.brainres.2011.03.014
37. Abbott NJ (2004) Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 45(4):545–552. doi:10.1016/j.neuint.2003.11.006
38. Koh L, Zakharov A, Johnston M (2005) Integration of the subarachnoid space and lymphatics: is it time to embrace a new concept of cerebrospinal fluid absorption? Cerebrospinal Fluid Res 2:6. doi:10.1186/1743-8454-2-6
39. Praetorius J (2007) Water and solute secretion by the choroid plexus. Pflugers Arch - Eur J Physiol 454(1):1–18. doi:10.1007/s00424-006-0170-6
40. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4(147):147ra111. doi:10.1126/scitranslmed.3003748
41. Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F, Xu Q, Wyatt JD et al (2009) Uniquely hominid features of adult human astrocytes. J Neurosci 29(10):3276–3287. doi:10.1523/JNEUROSCI.4707-08.2009
42. Federici T, Taub JS, Baum GR, Gray SJ, Grieger JC, Matthews KA, Handy CR, Passini MA et al (2012) Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther 19(8):852–859. doi:10.1038/gt.2011.130
43. Torashima T, Okoyama S, Nishizaki T, Hirai H (2006) In vivo transduction of murine cerebellar Purkinje cells by HIV-derived lentiviral vectors. Brain Res 1082(1):11–22. doi:10.1016/j.brainres.2006.01.104
44. Konno A, Shuvaev AN, Miyake N, Miyake K, Iizuka A, Matsuura S, Huda F, Nakamura K et al (2014) Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells. Cerebellum 13(1):29–41. doi:10.1007/s12311-013-0516-5
45. Miyake K, Miyake N, Yamazaki Y, Shimada T, Hirai Y (2012) Serotype-independent method of recombinant adeno-associated virus (AAV) vector production and purification. J Nippon Med School = Nippon Ika Daigaku zasshi 79(6):394–402